Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications

Area of Science:

• Oncology
• Surgical Pathology
• Gynecologic Oncology

Background:

• The sentinel lymph node (SLN) is the first node receiving lymphatic drainage from a tumor.
• SLN biopsy is crucial for staging various cancers, including melanoma, breast, and vulvar.
• This review evaluates SLN techniques and prognostic significance in gynecological malignancies.

Purpose of the Study:

• To review the technique and prognostic significance of sentinel lymph node biopsy in gynecological cancers.
• To assess the current evidence for SLN application in vulvar, cervical, endometrial, and ovarian malignancies.

Main Methods:

• Comprehensive literature search of MEDLINE and EMBASE databases up to 2008.
• Keywords included gynecological cancer types, lymph node metastases, sentinel node, technique, and prognosis.
• Inclusion of reviews, clinical studies, and case reports; exclusion of non-English articles.

Main Results:

• Detection methods for SLN varied across studies.
• Large trials confirm improved SLN detection and reduced morbidity in vulvar and cervical cancers.
• SLN protocols require refinement for endometrial cancer; less research exists for ovarian tumors.

Conclusions:

• SLN biopsy reliably predicts lymphatic basin metastasis in vulvar and cervical cancers.
• Further research is necessary to establish the role of SLN sampling in endometrial and ovarian cancers.
• SLN mapping aids in accurate staging and treatment planning for gynecological malignancies.